Literature DB >> 19624519

Preoperative chemoradiation vs radiation alone for stage II and III resectable rectal cancer: a meta-analysis.

T Latkauskas1, S Paskauskas, Z Dambrauskas, J Gudaityte, S Saladzinskas, A Tamelis, D Pavalkis.   

Abstract

AIM: The aim of this systematic literature review and meta-analysis was to compare preoperative radiotherapy (RT) with preoperative chemoradiotherapy (ChRT) in patients with stage II and III resectable rectal cancer.
METHOD: A comprehensive PubMed, Cohrane and Ovid electronic database search was performed. Articles published during the period 1960-2007 were included. The analysis included only randomized controlled trials, where patients with stage II and III resectable rectal cancer were randomized to one of at least two schedules of preoperative therapy including RT or ChRT followed by surgery. Secondary estimates for the experimental ChRT group were calculated and compared with the estimates pooled from trials which included short-course radiotherapy (SRT).
RESULTS: We identified 1017 articles including 242 clinical trials, 65 of which were randomized studies. Five trials from these randomized studies compared preoperative RT with conventional ChRT and only one included a group having SRT. The complete response rate was significantly better after preoperative chemoradiation compared with preoperative RT alone but the rate of toxicity was higher. Theoretically higher curative resection rates with less morbidity were found after ChRT compared with preoperative SRT.
CONCLUSION: Preoperative ChRT for patients with stage II and III resectable rectal cancer gives better complete response rates compared with RT alone but it also results in higher toxicity.
© 2010 The Authors. Colorectal Disease © 2010 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2010        PMID: 19624519     DOI: 10.1111/j.1463-1318.2009.02015.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

1.  Short-course preoperative radiotherapy combined with chemotherapy in resectable locally advanced rectal cancer: local control and quality of life.

Authors:  Patrizia Ciammella; Maria Paola Ruggieri; Maria Galeandro; Nunziata D'Abbiero; Alessandro Giunta; Cinzia Iotti
Journal:  Radiol Med       Date:  2013-06-25       Impact factor: 3.469

2.  Use of the gluteus maximus muscle as the neosphincter for restoration of anal function after abdominoperineal resection.

Authors:  J D Puerta Díaz; R Castaño Llano; L J Lombana; J I Restrepo; G Gómez
Journal:  Tech Coloproctol       Date:  2012-12-15       Impact factor: 3.781

3.  Prognostic Potential of Lymphocyte-C-Reactive Protein Ratio in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy.

Authors:  Yoshinaga Okugawa; Yuji Toiyama; Hiroyuki Fujikawa; Shozo Ide; Akira Yamamoto; Yusuke Omura; Chengzeng Yin; Kurando Kusunoki; Yukina Kusunoki; Hiromi Yasuda; Takeshi Yokoe; Junichiro Hiro; Masaki Ohi; Masato Kusunoki
Journal:  J Gastrointest Surg       Date:  2020-02-10       Impact factor: 3.452

4.  Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial.

Authors:  Tadas Latkauskas; Henrikas Pauzas; Laura Kairevice; Aleksandras Petrauskas; Zilvinas Saladzinskas; Rasa Janciauskiene; Jurate Gudaityte; Paulius Lizdenis; Saulius Svagzdys; Algimantas Tamelis; Dainius Pavalkis
Journal:  BMC Cancer       Date:  2016-12-01       Impact factor: 4.430

5.  Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer: Meta-analysis with trial sequential analysis of long-term survival data.

Authors:  Xin Wang; Bobo Zheng; Xinlan Lu; Ruhai Bai; Linlin Feng; Quan Wang; Yan Zhao; Shuixiang He
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.